This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

American Skin Association Announces New Member Of The Board J. Michael Pearson And New Education Council Member Ryan Weldon Of Valeant Pharmaceuticals International, Inc.

NEW YORK, April 24, 2013 /PRNewswire/ -- Howard P. Milstein, Chairman of American Skin Association (ASA), announced that J. Michael Pearson, Chairman and CEO of Valeant Pharmaceuticals International, Inc., has become a member of the ASA Board of Directors.

ASA's main mission is to advance research, champion skin health and drive public awareness regarding skin disease and melanoma/skin cancer. Through its national program of grants and awards, ASA has committed approximately $9 million to underwriting research by a new generation of scientists trained in dermatology and dedicated to overcoming the most serious forms of skin disease.

" Mike Pearson brings a tremendous wealth of experience to the Board. I look forward to working with him as we continue funding research, educating future generations on skin health and furthering the goal of defeating melanoma, skin cancer, and other skin diseases," said Howard P. Milstein.

"I am honored to become a part of ASA," Mike Pearson said. "Their efforts on behalf of skin disease and skin cancer have had a tremendous effect on increasing public awareness and their commitment to dermatology research has been a key driver in encouraging earlier diagnoses and new therapies. I look forward to working with the rest of the Board of Directors upholding and promoting the ASA's mission."

ASA also announced that Ryan Weldon, Executive Vice President and Company Group Chairman of the U.S. Dermatology Operations at Valeant Pharmaceuticals International, Inc., has become a member of its Education Council.  Weldon was appointed as an Executive Officer at Valeant in December 2012. Prior to that, he served as Vice President and General Manager of Aesthetics and General Manager of U.S. Neurology and Other at Valeant.

"Many of Valeant's acquisitions were once, or still are, some of the world's leading brands, transforming Valeant into one of the world's most important suppliers of dermatology drugs," said Humberto C. Antunes, President and CEO of Galderma and Co-Chair of ASA's Education Council.

ABOUT AMERICAN SKIN ASSOCIATIONLed by patients, families and their advocates working with the nation's foremost physicians and scientists, American Skin Association has evolved into an increasingly influential leader in efforts to defeat melanoma and other serious forms of skin disease. For over two decades, its mission has remained to advance research, champion skin health - particularly among young people, and raise public awareness about skin cancer and disease. For more information, visit www.americanskin.org.

SOURCE American Skin Association

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,989.19 +276.53 1.56%
S&P 500 2,084.53 +23.51 1.14%
NASDAQ 4,936.9260 +45.7070 0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs